Pipeline 2: Protein and Antibody Therapeutics
The world of protein-based therapeutics merits exploration, from novel constructs to enhanced in vivo effects, including antibodies as well as recombinant protein therapeutics. The varied designs, development and clinical data of fusion proteins, plus antibody-drug conjugates including linker technologies, specificity and enhancing properties, dovetail with discussion of bispecifics and how to create effective, multispecific antibodies that conquer cancer and other maladies. The Protein and Antibody Therapeutics pipeline showcases the array of therapeutics under development and their data of efficacy.
Recombinant Protein Therapeutics
Bispecific Antibody Therapeutics